Corbus Pharmaceuticals Holdings, Inc. (CRBP)
$11.10-$0.03 (-0.27%) Today
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 16,100 | $126K |
| Open-market sale | 5 | 38,238 | $365K |
| Grant or award | 2 | 250,009 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
28 Form 4 filings on record, the earliest from Oct 21, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Leonardo Viana Nicacio - Officer | Grant or award | Common Stock, par value $0.0001 per share | 58,333 | $0.00 | - | |
| Leonardo Viana Nicacio - Officer | Grant or award | Stock options (right to buy) | 191,676 | $0.00 | - | |
| Nishant C. Saxena - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 2,600 | $9.63 | $25K | |
| Yuval Cohen - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 17,000 | $10.08 | $171K | |
| Sean F. Moran - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 12,000 | $10.08 | $121K | |
| Winston Kung | Open-market sale | Common Stock, par value $0.0001 per share | 2,026 | $7.91 | $16K | |
| Anne Altmeyer | Open-market sale | Common Stock, par value $0.0001 per share | 2,412 | $7.91 | $19K | |
| John Kenneth Jenkins | Open-market sale | Common Stock, par value $0.0001 per share | 4,800 | $7.91 | $38K | |
| Nishant C. Saxena - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 4,500 | $7.33 | $33K | |
| Nishant C. Saxena - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 9,000 | $7.58 | $68K | |
| Nishant C. Saxena - Officer | Grant or award | Stock options (right to buy) | 192,300 | $0.00 | - | |
| Nishant C. Saxena - Officer | Grant or award | Common Stock, par value $0.0001 per share | 58,300 | $0.00 | - | |
| Winston Kung | Grant or award | Common Stock, par value $0.0001 per share | 3,800 | $0.00 | - | |
| Winston Kung | Grant or award | Stock options (right to buy) | 12,300 | $0.00 | - | |
| Rachelle Suzanne Jacques | Grant or award | Common Stock, par value $0.0001 per share | 3,800 | $0.00 | - | |
| Rachelle Suzanne Jacques | Grant or award | Stock options (right to buy) | 12,300 | $0.00 | - | |
| John Kenneth Jenkins | Grant or award | Common Stock, par value $0.0001 per share | 3,800 | $0.00 | - | |
| John Kenneth Jenkins | Grant or award | Stock options (right to buy) | 12,300 | $0.00 | - | |
| Anne Altmeyer | Grant or award | Common Stock, par value $0.0001 per share | 3,800 | $0.00 | - | |
| Anne Altmeyer | Grant or award | Stock options (right to buy) | 12,300 | $0.00 | - | |
| Yong Ben | Grant or award | Common Stock, par value $0.0001 per share | 3,800 | $0.00 | - | |
| Yong Ben | Grant or award | Stock options (right to buy) | 12,300 | $0.00 | - | |
| Brent Pfeiffenberger | Grant or award | Common Stock, par value $0.0001 per share | 7,500 | $0.00 | - | |
| Brent Pfeiffenberger | Grant or award | Stock options (right to buy) | 24,700 | $0.00 | - | |
| Dominic Smethurst - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 6,097 | $8.30 | $51K | |
| Ian Hodgson - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 847 | $7.38 | $6K | |
| Sean F. Moran - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 4,701 | $7.78 | $37K | |
| Yuval Cohen - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 13,871 | $7.78 | $108K | |
| Dominic Smethurst - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 3,285 | $8.09 | $27K | |
| Ian Hodgson - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 2,415 | $8.09 | $20K | |
| Dominic Smethurst - Officer | Grant or award | Common Stock, par value $0.0001 per share | 28,365 | $0.00 | - | |
| Dominic Smethurst - Officer | Grant or award | Stock options (right to buy) | 85,095 | $0.00 | - | |
| Sean F. Moran - Officer | Grant or award | Common Stock, par value $0.0001 per share | 28,082 | $0.00 | - | |
| Sean F. Moran - Officer | Grant or award | Stock options (right to buy) | 84,247 | $0.00 | - | |
| Yuval Cohen - Officer | Grant or award | Common Stock, par value $0.0001 per share | 50,000 | $0.00 | - | |
| Yuval Cohen - Officer | Grant or award | Stock options (right to buy) | 150,000 | $0.00 | - | |
| Ian Hodgson - Officer | Grant or award | Common Stock, par value $0.0001 per share | 28,365 | $0.00 | - | |
| Ian Hodgson - Officer | Grant or award | Stock options (right to buy) | 85,095 | $0.00 | - | |
| Yuval Cohen - Officer | Option exercise | Stock options (right to buy) | 8,973 | $0.00 | - | |
| Yuval Cohen - Officer | Option exercise | Common Stock, par value $0.0001 per share | 18,660 | $4.26 | $79K | |
| Yuval Cohen - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 18,660 | $17.01 | $317K | |
| Yuval Cohen - Officer | Option exercise | Common Stock, par value $0.0001 per share | 8,973 | $4.26 | $38K | |
| Yuval Cohen - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 8,973 | $17.14 | $154K | |
| Yuval Cohen - Officer | Option exercise | Stock options (right to buy) | 18,660 | $0.00 | - | |
| Sean F. Moran - Officer | Option exercise | Common Stock, par value $0.0001 per share | 12,981 | $4.26 | $55K | |
| Sean F. Moran - Officer | Open-market sale | Common Stock, par value $0.0001 per share | 12,981 | $17.02 | $221K | |
| Sean F. Moran - Officer | Option exercise | Stock options (right to buy) | 12,981 | $0.00 | - | |
| Anne Altmeyer | Option exercise | Common Stock, par value $0.0001 per share | 1,060 | $4.80 | $5K | |
| Anne Altmeyer | Open-market sale | Common Stock, par value $0.0001 per share | 1,060 | $20.50 | $22K | |
| Anne Altmeyer | Option exercise | Stock options (right to buy) | 1,060 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Stifel, Nicolaus & Company, Inc CIAS /FA | Officer | 17,000 | $171K | View on EDGAR | |
| Stifel, Nicolaus & Company, Inc CIAS /FA | Officer | 12,000 | $121K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had 8 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for CRBP runs to 28 Form 4 filings, the earliest from 2025-10-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
3 insider purchases of CRBP were filed in the last 90 days, totaling $126K.
5 insider sales of CRBP were filed in the last 90 days, totaling $365K.
This page tracks CRBP Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CRBP to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
